Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus.

Reidenberg MM, Drayer DE, Lorenzo B, Strom BL, West SL, Snyder ES, Freundlich B, Stolley PD.

Arthritis Rheum. 1993 Jul;36(7):971-3.

PMID:
8318043
3.

Gossypol and Na+, K+ ATPase from human erythrocytes.

Drayer DE, Reidenberg MM.

Contraception. 1988 Nov;38(5):579-83.

PMID:
2848657
4.

Antibodies: a rich source of novel chemical agents for pharmacological studies.

Cook CE, Drayer DE.

Trends Pharmacol Sci. 1988 Oct;9(10):373-5. Review. No abstract available.

PMID:
3078071
5.

Hydromorphone levels and pain control in patients with severe chronic pain.

Reidenberg MM, Goodman H, Erle H, Gray G, Lorenzo B, Leipzig RM, Meyer BR, Drayer DE.

Clin Pharmacol Ther. 1988 Oct;44(4):376-82. Erratum in: Clin Pharmacol Ther 1991 Mar;49(3):313.

PMID:
2458878
6.

Dose-dependent induction of anti-native DNA antibodies in cats by propylthiouracil.

Aucoin DP, Rubin RL, Peterson ME, Reidenberg MM, Drayer DE, Hurvitz AI, Lahita RG.

Arthritis Rheum. 1988 May;31(5):688-92.

PMID:
3259886
7.

Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in man.

Drayer DE.

Ther Drug Monit. 1988;10(1):1-7. Review. No abstract available.

PMID:
3287704
8.

A nonradioactive iothalamate method for measuring glomerular filtration rate and its use to study the renal handling of cibenzoline.

Reidenberg MM, Lorenzo BJ, Drayer DE, Kluger J, Nestor T, Regnier JC, Kowal BA, Bekersky I.

Ther Drug Monit. 1988;10(4):434-7.

PMID:
3201528
9.

On the use of drugs administered as racemates.

Drayer DE.

Clin Pharmacol Ther. 1987 Oct;42(4):364. No abstract available.

PMID:
3665336
10.

Accumulation of polyamines and their weak association with lower body temperature in elderly convalescent patients.

Restivo KM, Drayer DE, Orto L, Bond O, Reidenberg MM.

J Lab Clin Med. 1987 Aug;110(2):217-20.

PMID:
3598348
11.

Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits.

Cook CE, Seltzman TB, Tallent CR, Lorenzo B, Drayer DE.

J Pharmacol Exp Ther. 1987 Jun;241(3):779-85.

PMID:
3598902
12.
13.

Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.

Reidenberg MM, Drayer DE.

Angiology. 1986 Dec;37(12 Pt 2):968-71.

PMID:
2433971
14.

Stereoselective renal tubular secretion of quinidine and quinine.

Notterman DA, Drayer DE, Metakis L, Reidenberg MM.

Clin Pharmacol Ther. 1986 Nov;40(5):511-7.

PMID:
3769382
15.

Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview.

Drayer DE.

Clin Pharmacol Ther. 1986 Aug;40(2):125-33. No abstract available.

PMID:
3731675
16.

Propylthiouracil-induced immune-mediated disease in the cat.

Aucoin DP, Peterson ME, Hurvitz AI, Drayer DE, Lahita RG, Quimby FW, Reidenberg MM.

J Pharmacol Exp Ther. 1985 Jul;234(1):13-8.

PMID:
3874279
17.

Metoclopramide and chemotherapy-induced emesis.

Meyer BR, Lewin M, Pasmantier M, Drayer DE, Reidenberg MM.

Ann Intern Med. 1984 Jul;101(1):141-2. No abstract available.

PMID:
6375503
18.

Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals.

Meyer BR, Fischbein A, Rosenman K, Lerman Y, Drayer DE, Reidenberg MM.

Am J Med. 1984 Jun;76(6):989-98.

PMID:
6731470
19.

Development of antinuclear antibody in patients treated with high doses of captopril.

Reidenberg MM, Case DB, Drayer DE, Reis S, Lorenzo B.

Arthritis Rheum. 1984 May;27(5):579-81. No abstract available.

PMID:
6372800
20.

Pubertal changes in net renal tubular secretion of digoxin.

Linday LA, Drayer DE, Khan MA, Cicalese C, Reidenberg MM.

Clin Pharmacol Ther. 1984 Apr;35(4):438-46.

PMID:
6368090
21.

Optimizing metoclopramide control of cisplatin-induced emesis.

Meyer BR, Lewin M, Drayer DE, Pasmantier M, Lonski L, Reidenberg MM.

Ann Intern Med. 1984 Mar;100(3):393-5.

PMID:
6538075
22.

Simultaneous determination of dipyrone metabolites in plasma by high-performance liquid chromatography.

Katz EZ, Granit L, Drayer DE, Levy M.

J Chromatogr. 1984 Feb 10;305(2):477-84. No abstract available.

PMID:
6707174
23.

Alteration of drug-protein binding in renal disease.

Reidenberg MM, Drayer DE.

Clin Pharmacokinet. 1984 Jan;9 Suppl 1:18-26.

PMID:
6705423
25.

Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy.

Alderman MH, Melcher L, Drayer DE, Reidenberg MM.

N Engl J Med. 1983 Nov 17;309(20):1213-7.

PMID:
6633570
26.

Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.

Drayer DE, Lorenzo B, Werns S, Reidenberg MM.

Clin Pharmacol Ther. 1983 Jul;34(1):14-22.

27.

N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.

Sherman RL, Drayer DE, Leyland-Jones BR, Reidenberg MM.

Arch Intern Med. 1983 Jun;143(6):1183-5.

PMID:
6190447
30.

Microsomal hydroxylation as measured by pentobarbital elimination in patients with idiopathic systemic lupus erythematosus.

Drayer DE, Lorenzo B, Lahita RG, Robbins WC, Reidenberg MM.

Clin Pharmacol Ther. 1982 Aug;32(2):195-200.

PMID:
7094506
31.

Comparison of antiarrhythmic effects of procainamide, N-acetylprocainamide, and p-hydroxy-N-(3-diethylaminopropyl)benzamide.

Reynolds RD, Burmeister WE, Calzadilla SV, Lee RJ, Reidenberg MM, Drayer DE.

Proc Soc Exp Biol Med. 1982 Feb;169(2):156-60. No abstract available.

PMID:
6174988
32.

Age and renal clearance of cimetidine.

Drayer DE, Romankiewicz J, Lorenzo B, Reidenberg MM.

Clin Pharmacol Ther. 1982 Jan;31(1):45-50.

PMID:
7053303
33.

Long-term antiarrhythmic therapy with acetylprocainamide.

Kluger J, Leech S, Reidenberg MM, Lloyd V, Drayer DE.

Am J Cardiol. 1981 Dec;48(6):1124-32.

PMID:
6171156
34.

Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome.

Kluger J, Drayer DE, Reidenberg MM, Lahita R.

Ann Intern Med. 1981 Jul;95(1):18-23.

PMID:
6166229
35.
37.

Aging and renal clearance of procainamide and acetylprocainamide.

Reidenberg MM, Camacho M, Kluger J, Drayer DE.

Clin Pharmacol Ther. 1980 Dec;28(6):732-5.

PMID:
6160015
38.

Renal injury in patients with rheumatoid arthritis treated with gold.

Merle LJ, Reidenberg MM, Camacho MT, Jones BR, Drayer DE.

Clin Pharmacol Ther. 1980 Aug;28(2):216-22.

PMID:
6994990
39.

Acetylator phenotype in idiopathic systemic lupus erythematosus.

Reidenberg MM, Levy M, Drayer DE, Zylber-Katz E, Robbins WC.

Arthritis Rheum. 1980 May;23(5):569-73.

PMID:
7378086
40.

Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.

Drayer DE, Hughes M, Lorenzo B, Reidenberg MM.

Clin Pharmacol Ther. 1980 Jan;27(1):72-5.

PMID:
7351119
41.

Drug therapy in renal failure.

Reidenberg MM, Drayer DE.

Annu Rev Pharmacol Toxicol. 1980;20:45-54. Review. No abstract available.

PMID:
6992702
42.

Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.

Lahita R, Kluger J, Drayer DE, Koffler D, Reidenberg MM.

N Engl J Med. 1979 Dec 20;301(25):1382-5. No abstract available.

PMID:
91972
43.

Unusual cause of theophylline toxicity.

Gotz VP, Drayer DE, Schned ES, Reidenberg MM.

N Y State J Med. 1979 Jul;79(8):1232-4. No abstract available.

PMID:
287921
44.

Alterations in state in apneic pre-term infants receiving theophylline.

Dietrich J, Krauss AN, Reidenberg M, Drayer DE, Auld PA.

Clin Pharmacol Ther. 1978 Oct;24(4):474-8.

PMID:
688737
45.

Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.

Drayer DE, Lowenthal DT, Restivo KM, Schwartz A, Cook CE, Reidenberg MM.

Clin Pharmacol Ther. 1978 Jul;24(1):31-9.

PMID:
657716
46.

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.

Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA.

N Engl J Med. 1978 May 25;298(21):1157-9.

PMID:
306574
47.

Effects of renal disease upon drug disposition.

Reidenberg MM, Drayer DE.

Drug Metab Rev. 1978;8(2):293-302. Review. No abstract available.

PMID:
363386
48.

Aromatic amines and hydrazines drug acetylation, and lupus erythematodes.

Reidenberg MM, Drayer DE.

Hum Genet Suppl. 1978;(1):57-63. No abstract available.

PMID:
285033
49.
50.

Clinical consequences of polymorphic acetylation of basic drugs.

Drayer DE, Reidenberg MM.

Clin Pharmacol Ther. 1977 Sep;22(3):251-8.

PMID:
19187

Supplemental Content

Loading ...
Support Center